Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 8,754 | 16,521 | 8,862 | 9,202 | 10,828 |
| Cost of Goods | 1,650 | 2,610 | 1,040 | N/A | 1,650 |
| Gross Profit | 7,090 | 13,900 | 7,810 | 9,202 | 9,170 |
| Operating Expenses | 5,420 | 7,460 | 4,700 | 0 | 5,770 |
| Operating Income | 2,334 | 7,061 | 3,162 | 9,202 | 4,058 |
| Interest Expense | 190 | 540 | 150 | 0 | 110 |
| Other Income | 36 | -31 | -2 | 0 | 12 |
| Pre-tax Income | 2,180 | 6,490 | 3,010 | 9,202 | 3,960 |
| Income Tax | 910 | 1,600 | 710 | N/A | 750 |
| Net Income Continuous | 740 | 3,336 | 1,560 | 1,993 | 2,190 |
| Net Income | $740 | $3,336 | $1,560 | $1,993 | $2,190 |
| EPS Basic Total Ops | 0.02 | 0.08 | 0.04 | 0.05 | 0.05 |
| EPS Basic Continuous Ops | 0.02 | 0.08 | 0.04 | 0.05 | 0.05 |
| EPS Diluted Total Ops | 0.02 | 0.08 | 0.04 | 0.05 | 0.05 |
| EPS Diluted Continuous Ops | 0.02 | 0.08 | 0.04 | 0.05 | 0.05 |
| EBITDA(a) | $2,334 | $7,061 | $3,162 | $9,202 | $4,058 |